AUG 19, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Colistimethate (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for labeling update to colistimethate sodium injection; this is a regulatory action record without clinical trial data.
Reported
Product strength150 mg base per vial
Approval date2026-08-19